Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIF 1149 BS in healthy male volunteers
NCT02209714Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 1999
- Primary completion
- Feb 2000
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in cough comparing BIIF 1149 BS with Placebo (2 arms). Primary endpoints: Clinically relevant changes in vital functions (blood pressure, pulse rate) at 8 days, Clinically relevant changes in electrocardiogram at 8 days and 2 more. Started Nov 1999; status: completed.
02
Drugs
figopitant
03
Conditions
cough
Beyond the preview
Go deeper on NCT02209714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209714.